SCHEMBL913533

SCHEMBL913533

c1ccc(-c2cc3cccnc3c3ncccc23)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.58
CCR8 P51685 5/20 0.58
L3MBTL1 Q9Y468 4/20 0.58
TOP1 P11387 4/20 0.53
ALDH1A1 P00352 3/20 0.51
MAPT P10636 3/20 0.50
CYP11B1 P15538 1/20 0.50
CCR5 P51681 3/20 0.48
KDM4E B2RXH2 2/20 0.48
HSP90AA1 P07900 2/20 0.48
LMNA P02545 2/20 0.48
GMNN O75496 1/20 0.48
TP53 P04637 1/20 0.48
MMP2 P08253 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
MMP9 P14780 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29441295 1.00 CCR1 (0.58) CCR1CCR8L3MBTL1TOP1ALDH1A1
SCHEMBL15372035 0.93 ALDH1A1 (0.61) CCR1CCR8L3MBTL1TOP1ALDH1A1
SCHEMBL17899329 0.92 CCR1 (0.61) CCR1CCR8L3MBTL1TOP1ALDH1A1
SCHEMBL20726912 0.92 CCR1 (0.50) CCR1CCR8L3MBTL1TOP1ALDH1A1
SCHEMBL17125611 0.91 CCR1 (0.59) CCR1CCR8L3MBTL1TOP1ALDH1A1
SCHEMBL20726711 0.91 CCR1 (0.49) CCR1CCR8L3MBTL1TOP1ALDH1A1
SCHEMBL18806863 0.89 CCR1 (0.58) CCR1CCR8L3MBTL1ALDH1A1MAPT
SCHEMBL2450872 0.89 L3MBTL1 (0.61) CCR1CCR8L3MBTL1TOP1ALDH1A1
SCHEMBL29444844 0.89 L3MBTL1 (0.61) CCR1CCR8L3MBTL1TOP1ALDH1A1
SCHEMBL30555210 0.89 L3MBTL1 (0.61) CCR1CCR8L3MBTL1TOP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114163428-A Preparation method of topramezone 江苏七洲绿色科技研究院有限公司 2022-03-11 CN claimed
US-9428529-B2 Process for purification of trivalent phosphorous ligands that can be used for preparation of catalysts DOW TECHNOLOGY INVESTMENTS LLC (US) 2016-08-30 US claimed
US-9193746-B2 Luminescent metal complexes and associated technology BIOTIUM, INC. (US) 2015-11-24 US claimed
US-20080145526-A1 Luminescent Metal Complexes and Associated Technology BIOTIUM, INC. 2008-06-19 US claimed
US-7238832-B2 Production method of a coupling compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-07-03 US claimed
EP-1449580-B1 Production method of a cross-coupling compound from an alkyl halide and an organoboron compound SUMITOMO CHEMICAL CO (JP) 2005-12-28 EP claimed
US-20040167364-A1 Production method of a coupling compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-26 US claimed
EP-1449580-A1 Production method of a cross-coupling compound from an alkyl halide and an organoboron compound Sumitomo Chemical Co.,Ltd. (JP) 2004-08-25 EP claimed
WO-1999031513-A1 METHOD AND COMPOSITION FOR CHARACTERIZING A SAMPLE CONTAINING A SAMPLE LIPID AND AN ASSAY KIT LAKOWICZ JOSEPH R (US) 1999-06-24 WO claimed
US-4464279-A Magnetic recording medium KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1984-08-07 US claimed
JP-58069841-A None JP disclosed
CN-111936505-B Tertiary alkyl-substituted polycyclic aromatic compounds and uses thereof 学校法人关西学院 2024-07-02 CN disclosed
CN-113412265-B Polycyclic aromatic compounds 学校法人关西学院 2024-05-03 CN disclosed
CN-111527094-B Compound, polymer compound, material for organic element, organic electroluminescent element, display device, and lighting device 学校法人关西学院 2024-03-26 CN disclosed
CN-113013366-B Organic electroluminescent element, display device, lighting device, and anthracene compound 学校法人关西学院 2024-03-26 CN disclosed
JP-S5869841-A STABILIZER FOR HYDROXYLAMINE NISSHIN KAKO KK 1983-04-26 JP disclosed
US-4242441-A PROCESSING WITH A PEROXO ACID OR SALT AND A COMPLEXING AGENT TO OXIDATIVELY BLEACH THE DYE FUJI PHOTO FILM CO., LTD. (JP) 1980-12-30 US disclosed
EP-0005505-A2 Open-cell foamed polyurethane resins containing compounds forming chelates and/or complexes of chelates, process for their preparation and their application to the adsorption of heavy-metal ions from waste water BASF Aktiengesellschaft (DE) 1979-11-28 EP disclosed
US-4143075-A RHODIUM-CARBON MONOXIDE-TRIARYLPHOSPHINE CATALYST, SEQUESTERING IRON SALT CONTAMINANTS UNION CARBIDE CORPORATION (US) 1979-03-06 US disclosed
US-3951833-A Method for preserving functional fluids and liquid hydrocarbon fuels with selected 1,10-phenanthrolines OLIN CORPORATION (US) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167364-A1 Production method of a coupling compound PYM1, BRIX1, CXCR1 CCR1 94/4885CCR8 1500/4885L3MBTL1 3096/4885
US-20080145526-A1 Luminescent Metal Complexes and Associated Technology CLTA, CLTB, CACYBP CCR1 3826/4885CCR8 4253/4885L3MBTL1 562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.